摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-氧代-2-硫代噻唑并噁唑烷-3-基)苯磺酰胺 | 301343-38-4

中文名称
N-(4-氧代-2-硫代噻唑并噁唑烷-3-基)苯磺酰胺
中文别名
——
英文名称
3-(benzenesulfonylamino)-4-oxo-2-thionothiazolidine
英文别名
N-(4-oxo-2-thioxothiazolidin-3-yl)benzenesulfonamide;3-(benzenesulfonylamino)rhodanine;N-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)benzenesulfonamide
N-(4-氧代-2-硫代噻唑并噁唑烷-3-基)苯磺酰胺化学式
CAS
301343-38-4
化学式
C9H8N2O3S3
mdl
——
分子量
288.372
InChiKey
JLAFUTNZTWXZJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    132
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(4-氧代-2-硫代噻唑并噁唑烷-3-基)苯磺酰胺 在 CoCl2 2,2'-联吡啶sodium hydroxide 、 sodium tetrahydroborate 、 sodium acetate 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 6.0h, 生成 5-(3,4-Dichlorobenzyl)-3-(benzenesulfonylamino)-4-hydroxy-2-thionothiazolidine
    参考文献:
    名称:
    SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase
    摘要:
    Novel non-nucleoside inhibitors of the HCV RNA polymerase (NS5b) with sub-micromolar biochemical potency have been identified which are selective for the inhibition of HCV NS5b over other polymerases. The structures of the complexes formed between several of these inhibitors and HCV NS5b were determined by X-ray crystallography, and the inhibitors were found to bind in an allosteric binding site separate from the active site. Structure-activity relationships and structural studies have identified the mechanism of action for compounds in this series, several of which possess drug-like properties, as unique, reversible, covalent inhibitors of HCV NS5b.
    DOI:
    10.1021/jm050859x
  • 作为产物:
    参考文献:
    名称:
    Thermodynamics of Substituted Rhodanine III: Potentiometric and Spectrophotometric Studies of Complexes of Some Transition Metals with 3-Phenylsulfonamidorhodanine
    摘要:
    The dissociation constants of 3-phenylsulfonamidorhodanine (PSR) were determined potentiometrically in 0.1 M KCI and 20% (v/v) ethanol-water. The stepwise stability constants of the complexes of Mn2+, Co2+, Ni2+, Cu2+, Zn2+, La3+, Ce3+, Gd3+, UO22+ and Th4+ with PSR were determined. The stabilities of the complexes were found as follows: Th4+ > UO22+ > Gd3+ > Ce3+ > La3+ > Mn2+ < Co2+ < Ni2+ < Cu2+ > Zn2+. The thermodynamic parameters for PSR and its complexes were evaluated and discussed. The dissociation process is non-spontaneous, endothermic, and entropically unfavourable. The formation of the complexes was found to be spontaneous, exothermic or endothermic (depending on the metal), and entropically favourable. The stoichiometries of the complexes were determined spectrophotometrically and indicate the formation of 1:1 and 1:2 (metal:ligand) complexes.
    DOI:
    10.1007/pl00010137
点击查看最新优质反应信息

文献信息

  • Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
    作者:Khadidja Bourahla、Solène Guihéneuf、Emmanuelle Limanton、Ludovic Paquin、Rémy Le Guével、Thierry Charlier、Mustapha Rahmouni、Emilie Durieu、Olivier Lozach、François Carreaux、Laurent Meijer、Jean-Pierre Bazureau
    DOI:10.3390/ph14111086
    日期:——

    Here, we report on the synthesis of libraries of new 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones 3 (twenty-two compounds) and new 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones 5 (twenty-four compounds) with stereo controlled Z-geometry under microwave irradiation. The 46 designed final compounds were tested in order to determine their activity against four representative protein kinases (DYR1A, CK1, CDK5/p25, and GSK3α/β). Among these 1,3-thiazolidin-4-ones, the molecules (5Z) 5-(4-hydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one 3e (IC50 0.028 μM) and (5Z)-5-benzo[1,3]dioxol-5-ylmethylene-2-(pyridin-2-yl)amino-1,3-thiazol-4(5H)-one 5s (IC50 0.033 μM) were identified as lead compounds and as new nanomolar DYRK1A inhibitors. Some of these compounds in the two libraries have been also evaluated for their in vitro inhibition of cell proliferation (Huh7 D12, Caco2, MDA-MB 231, HCT 116, PC3, and NCI-H2 tumor cell lines). These results will enable us to use the 1,3-thiazolidin-4-one core as pharmacophores to develop potent treatment for neurological or oncological disorders in which DYRK1A is fully involved.

    在这里,我们报道了在微波辐射下合成了新的5-芳基亚基-2-硫代-1,3-噻唑啉-4-酮3类(二十二个化合物)和新的2-氨基-5-芳基亚基-1,3-噻唑-4(5H)-酮5类(二十四个化合物),具有立体控制的Z-几何构型。设计的46个最终化合物被测试,以确定它们对四种代表性蛋白激酶(DYR1A、CK1、CDK5/p25和GSK3α/β)的活性。在这些1,3-噻唑啉-4-酮中,分子(5Z)5-(4-羟基苯基亚基)-2-硫代-1,3-噻唑啉-4-酮3e(IC50为0.028μM)和(5Z)-5-苯并[1,3]二氧杂环-5-基亚甲基-2-(吡啶-2-基)氨基-1,3-噻唑-4(5H)-酮5s(IC50为0.033μM)被确定为引物化合物和新的纳摩尔级DYRK1A抑制剂。这两个库中的一些化合物也已评估其对细胞增殖的体外抑制作用(Huh7 D12、Caco2、MDA-MB 231、HCT 116、PC3和NCI-H2肿瘤细胞系)。这些结果将使我们能够利用1,3-噻唑啉-4-酮核作为药效团,开发用于治疗DYRK1A完全参与的神经或肿瘤疾病的有效治疗方法。
  • NS5B HCV polymerase inhibitors
    申请人:Tularik Inc.
    公开号:US20020142290A1
    公开(公告)日:2002-10-03
    Compounds, compositions and methods are provided that are useful in the treatment and prevention of certain viral infections and associated diseases. In particular, the compounds of the invention inhibit the activity of a viral RNA polymerase. The subject methods are particularly useful in the treatment of diseases causes by hepatitis C virus infection.
    提供了一些在治疗和预防特定病毒感染和相关疾病中有用的化合物、组合物和方法。具体来说,本发明的化合物抑制了病毒RNA聚合酶的活性。这些方法特别适用于治疗由丙型肝炎病毒感染引起的疾病。
  • NS5B HVC polymerase inhibitors
    申请人:Tularik Inc.
    公开号:US06727267B2
    公开(公告)日:2004-04-27
    Compounds, compositions and methods are provided that are useful in the treatment and prevention of certain viral infections and associated diseases. In particular, the compounds of the invention inhibit the activity of a viral RNA polymerase. The subject methods are particularly useful in the treatment of diseases causes by hepatitis C virus infection.
    本发明提供了在治疗和预防某些病毒感染和相关疾病方面有用的化合物、组合物和方法。特别是,本发明的化合物抑制病毒RNA聚合酶的活性。本方法在治疗由丙型肝炎病毒感染引起的疾病方面特别有用。
  • Thermodynamics of Substituted Rhodanine III: Potentiometric and Spectrophotometric Studies of Complexes of Some Transition Metals with 3-Phenylsulfonamidorhodanine
    作者:Ashraf A. El-Bindary、Mohammed M. Ghoneim、Adel Z. El-Sonbati、Sahar A. Barakat
    DOI:10.1007/pl00010137
    日期:1998.12
    The dissociation constants of 3-phenylsulfonamidorhodanine (PSR) were determined potentiometrically in 0.1 M KCI and 20% (v/v) ethanol-water. The stepwise stability constants of the complexes of Mn2+, Co2+, Ni2+, Cu2+, Zn2+, La3+, Ce3+, Gd3+, UO22+ and Th4+ with PSR were determined. The stabilities of the complexes were found as follows: Th4+ > UO22+ > Gd3+ > Ce3+ > La3+ > Mn2+ < Co2+ < Ni2+ < Cu2+ > Zn2+. The thermodynamic parameters for PSR and its complexes were evaluated and discussed. The dissociation process is non-spontaneous, endothermic, and entropically unfavourable. The formation of the complexes was found to be spontaneous, exothermic or endothermic (depending on the metal), and entropically favourable. The stoichiometries of the complexes were determined spectrophotometrically and indicate the formation of 1:1 and 1:2 (metal:ligand) complexes.
  • US6727267B2
    申请人:——
    公开号:US6727267B2
    公开(公告)日:2004-04-27
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐